These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 660683)

  • 21. Drug dosing adjustments in patients with chronic kidney disease.
    Munar MY; Singh H
    Am Fam Physician; 2007 May; 75(10):1487-96. PubMed ID: 17555141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimation of glomerular filtration rate from the serum creatinine concentration.
    Smith SA
    Postgrad Med J; 1988 Mar; 64(749):204-8. PubMed ID: 3174538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A set of simple aids to drug dosage adjustment in renal insufficiency.
    Janků I; Modr Z; Krebs V
    Int J Clin Pharmacol Ther Toxicol; 1990 Jan; 28(1):27-32. PubMed ID: 2303310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computerized screening for appropriate dosing of renally eliminated medications.
    Skinner R; Caldwell J; Vitale P
    Proc Annu Symp Comput Appl Med Care; 1994; ():971. PubMed ID: 7950075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjusting eptifibatide doses for renal impairment: a model of dosing agreement among various methods of estimating creatinine clearance.
    Healy MF; Speroni KG; Eugenio KR; Murphy PM
    Ann Pharmacother; 2012 Apr; 46(4):477-83. PubMed ID: 22474135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug use in renal failure.
    Henrich WL; Anderson RJ
    Postgrad Med; 1978 Nov; 64(5):153-63. PubMed ID: 714830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug Dosing and Estimated Renal Function - Any Step Forward from Effersoe?
    Hornum M; Feldt-Rasmussen B
    Nephron; 2017; 136(4):268-272. PubMed ID: 28214841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of equations for dosing of medications requiring renal adjustment.
    Lessard BA; Zaiken K
    J Am Pharm Assoc (2003); 2013; 53(1):54-7. PubMed ID: 23636156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Augmented renal clearance in the ICU: results of a multicenter observational study of renal function in critically ill patients with normal plasma creatinine concentrations*.
    Udy AA; Baptista JP; Lim NL; Joynt GM; Jarrett P; Wockner L; Boots RJ; Lipman J
    Crit Care Med; 2014 Mar; 42(3):520-7. PubMed ID: 24201175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of kidney disease on drug disposition: An assessment of industry studies submitted to the FDA for new chemical entities 1999-2010.
    Matzke GR; Dowling TC; Marks SA; Murphy JE
    J Clin Pharmacol; 2016 Apr; 56(4):390-8. PubMed ID: 26238947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum creatinine and drug half-lives in renal failure.
    Perrier D; Gibaldi M
    JAMA; 1972 Aug; 221(8):918. PubMed ID: 5068187
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacokinetics, safety, and efficacy of lenalidomide plus dexamethasone in patients with multiple myeloma and renal impairment.
    Bridoux F; Chen N; Moreau S; Arnulf B; Moumas E; Abraham J; Desport E; Jaccard A; Fermand JP
    Cancer Chemother Pharmacol; 2016 Jul; 78(1):173-82. PubMed ID: 27286995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The development of a drug dosage adjustment service for patients with renal impairment.
    Libiszewski D
    J Clin Hosp Pharm; 1981 Mar; 6(1):39-49. PubMed ID: 7345095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A systematic comparison of cockcroft-gault and modification of diet in renal disease equations for classification of kidney dysfunction and dosage adjustment.
    Park EJ; Wu K; Mi Z; Dong T; Lawrence JP; Ko CW; Huang SM; Zhang L; Crentsil V; Zhang J; Xu NN
    Ann Pharmacother; 2012 Sep; 46(9):1174-87. PubMed ID: 22932303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose adjustment in patients with liver disease.
    Delcò F; Tchambaz L; Schlienger R; Drewe J; Krähenbühl S
    Drug Saf; 2005; 28(6):529-45. PubMed ID: 15924505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pharmacokinetics of angiotensin converting enzyme inhibitors in patients with renal impairment.
    Begg EJ; Bailey RR; Lynn KL; Robson RA; Frank GJ; Olson SC
    J Hypertens Suppl; 1989 Sep; 7(5):S29-32. PubMed ID: 2681603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic study of memantine in healthy and renally impaired subjects.
    Periclou A; Ventura D; Rao N; Abramowitz W
    Clin Pharmacol Ther; 2006 Jan; 79(1):134-43. PubMed ID: 16413248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prescribing for older people with chronic renal impairment.
    Bell JS; Blacker N; Leblanc VT; Alderman CP; Phillips A; Rowett D; Rossi S; Frank O; Husband A
    Aust Fam Physician; 2013; 42(1-2):24-8. PubMed ID: 23529455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dosing adjustment of 10 antimicrobials for patients with renal impairment.
    Preston SL; Briceland LL; Lomaestro BM; Lesar TS; Bailie GR; Drusano GL
    Ann Pharmacother; 1995 Dec; 29(12):1202-7. PubMed ID: 8672821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations.
    Bartelink IH; Rademaker CM; Schobben AF; van den Anker JN
    Clin Pharmacokinet; 2006; 45(11):1077-97. PubMed ID: 17048973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.